A naukri.com initiative
Bioengineer
1w
406
Image Credit: Bioengineer
S-Ketamine Eases Post-Chemo Pain in Children
- Groundbreaking study reveals efficacy of S-ketamine in managing post-chemo pain in children undergoing surgery.
- Chemotherapy alters neurophysiological pathways, leading to heightened pain sensitivity post-surgery in pediatric patients.
- S-ketamine, an NMDA receptor antagonist, modulates pain perception in children with prior chemotherapy exposure.
- Clinical trial shows S-ketamine reduces postoperative pain scores and opioid-related adverse effects in children.
- S-ketamine counteracts neuroinflammatory cascades and rebalances neurotransmission disrupted by chemotherapy.
- Research indicates S-ketamine's potential in neuroprotection and modulation of pain pathways in pediatric oncology patients.
- Study emphasizes personalized anesthesia for pediatric patients based on individual neurochemistry and pain phenotypes.
- S-ketamine's targeted modulation of pain amplification mechanisms offers a paradigm shift in analgesic drug development.
- Investigation underscores the significance of cross-disciplinary collaboration in advancing pediatric pain management.
- Emphasis on cautious optimism, long-term safety data, and larger trials to validate S-ketamine's efficacy and dosing in diverse populations.
Read Full Article
24 Likes
For uninterrupted reading, download the app